These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9580203)

  • 1. [Biological markers of activity in chronic inflammatory bowel disease].
    Sánchez Lombraña J; Palacio MA; Carbajal C; Vivas S; Pérez R; Rodrigo L
    Rev Esp Enferm Dig; 1997 Nov; 89(11):855-8. PubMed ID: 9580203
    [No Abstract]   [Full Text] [Related]  

  • 2. The certain uncertainty of measuring disease activity in IBD.
    Ullman TA; Palmon R
    J Clin Gastroenterol; 2007 Feb; 41(2):123-5. PubMed ID: 17245207
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process].
    Krzesiek E; Pytrus T; Kosmowska A; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):455-9. PubMed ID: 19205373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Established and emerging biological activity markers of inflammatory bowel disease.
    Nielsen OH; Vainer B; Madsen SM; Seidelin JB; Heegaard NH
    Am J Gastroenterol; 2000 Feb; 95(2):359-67. PubMed ID: 10685736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.
    Dotan I
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):265-74. PubMed ID: 19072419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
    McCann TM; Ridyard AE; Else RW; Simpson JW
    J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: marker of inflammatory bowel disease.
    Srinivasan R; Colman RW
    Am J Gastroenterol; 2000 Jul; 95(7):1849-50. PubMed ID: 10926011
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: biological activity markers in inflammatory bowel disease.
    Desai D; Faubion WA; Sandborn WJ
    Aliment Pharmacol Ther; 2007 Feb; 25(3):247-55. PubMed ID: 17217454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological markers in inflammatory bowel disease: differences among populations and limitations of their application].
    Barahona-Garrido J; Hernández-Calleros J; Sarti HM; Cabiedes J; Yamamoto-Furusho JK
    Gastroenterol Hepatol; 2009 May; 32(5):380-1. PubMed ID: 19457592
    [No Abstract]   [Full Text] [Related]  

  • 10. A critical evaluation of serologic markers for inflammatory bowel disease.
    Austin GL; Herfarth HH; Sandler RS
    Clin Gastroenterol Hepatol; 2007 May; 5(5):545-7. PubMed ID: 17433787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
    Desreumaux P; Bourreille A; Colombel JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating ghrelin levels in patients with inflammatory bowel disease.
    Peracchi M; Bardella MT; Caprioli F; Massironi S; Conte D; Valenti L; Ronchi C; Beck-Peccoz P; Arosio M; Piodi L
    Gut; 2006 Mar; 55(3):432-3. PubMed ID: 16474110
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can serologic markers help determine prognosis and guide therapy?
    Dubinsky M
    Dig Dis; 2010; 28(3):424-8. PubMed ID: 20926867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of thrombophilic abnormalities in Turkish children with inflammatory bowel disease.
    Saltik IN; Ozen H; Gürakan F; Yüce A; Koçak N
    Am J Gastroenterol; 2000 Sep; 95(9):2395. PubMed ID: 11007257
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
    Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
    Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymes in feces: useful markers of chronic inflammatory bowel disease.
    Angriman I; Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Sturniolo GC; D'Amico DF; Plebani M
    Clin Chim Acta; 2007 May; 381(1):63-8. PubMed ID: 17368600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies.
    Meier C; Plevy S
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):667-74. PubMed ID: 17968338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers and bone densitometry in inflammatory bowel disease.
    Ledro Cano D; Torres Domínguez Y; Castro Laria L; Sáenz Dana M; Herrerías Esteban JM; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2000 Sep; 92(9):595-600. PubMed ID: 11138241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.